To further investigate the timing of POLE mutations and their consequences for tumour development, we performed WGS on six cancers (five endometrial; one colorectal), all of which harboured the most common pathogenic POLE exonuclease domain variant – a proline to arginine substitution at codon 286 (POLEP286R) (Figure 2A). This evidence concerns the gene POLE and cancer.